MILLUZZO, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 785
EU - Europa 542
AS - Asia 194
AF - Africa 71
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.595
Nazione #
US - Stati Uniti d'America 770
IT - Italia 299
SG - Singapore 115
IE - Irlanda 100
CN - Cina 68
CI - Costa d'Avorio 44
DE - Germania 35
UA - Ucraina 30
CZ - Repubblica Ceca 17
SN - Senegal 17
BE - Belgio 14
CA - Canada 14
RU - Federazione Russa 14
NG - Nigeria 10
FI - Finlandia 7
FR - Francia 7
GB - Regno Unito 4
GR - Grecia 4
VN - Vietnam 4
CH - Svizzera 3
NL - Olanda 3
TR - Turchia 3
AT - Austria 2
AU - Australia 2
IN - India 2
SE - Svezia 2
EU - Europa 1
JP - Giappone 1
MX - Messico 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 1.595
Città #
Santa Clara 254
Dublin 94
Singapore 93
Chicago 86
Catania 78
Chandler 70
Boardman 50
Abidjan 44
Jacksonville 41
Civitanova Marche 25
Ashburn 23
Cambridge 23
Lawrence 22
Andover 20
Dakar 17
Des Moines 16
Brno 15
Brussels 13
Nanjing 13
Rome 12
Bremen 11
Toronto 11
Abuja 10
Grafing 10
Milan 10
Munich 10
Portici 9
Wilmington 9
Bronte 8
Palermo 7
Hebei 6
San Giovanni la Punta 6
Nanchang 5
Pescara 5
Bari 4
Beijing 4
Dong Ket 4
Helsinki 4
Messina 4
San Mateo 4
Shenyang 4
Casalecchio di Reno 3
Falls Church 3
Fiumicino 3
Jiaxing 3
Lappeenranta 3
Los Angeles 3
Misterbianco 3
Pozzo Di Gotto 3
Saint Petersburg 3
San Francisco 3
Agrigento 2
Amsterdam 2
Ann Arbor 2
Cagliari 2
Carrara 2
Changsha 2
Cleveland 2
Gela 2
Houston 2
Knoxville 2
Marostica 2
Mascalucia 2
Melilli 2
Naples 2
Nizza di Sicilia 2
Orta 2
Ottawa 2
Pozzallo 2
Quintano 2
Reggio Emilia 2
Rosolini 2
Saponara 2
Soliera 2
Tianjin 2
Vienna 2
Vizzini 2
Washington 2
Adrano 1
Bergamo 1
Boydton 1
Delhi 1
Edinburgh 1
Esslingen am Neckar 1
Florence 1
Folkestone 1
Foshan 1
Frankfurt Am Main 1
Frankfurt am Main 1
Giulianova 1
Guangzhou 1
Istanbul 1
Kunming 1
Ladispoli 1
Lentini 1
Lusciano 1
Mexico City 1
Nanaimo 1
Ningbo 1
Norwalk 1
Totale 1.260
Nome #
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 80
Body mass index is related to short term retinal worsening in type 2 diabetes patients treated with anticancer drugs 78
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 77
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 70
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 66
Screening e diagnosi di diabete gestazionale 58
Insulin receptor isoforms in cancer 53
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 50
Screening e diagnosi del diabete gestazionale. 48
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta 48
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review 47
I nuovi criteri diagnostici hanno modificato l’impatto del diabete gestazionale? 47
Type 2 diabetes and cancer: problems and suggestions for best patient management 47
Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors 47
Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review 45
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 44
Glicemia 1 h dopo carico orale di glucosio in donne normotolleranti con pregresso diabete gestazionale 44
Risk for Coexistent Autoimmune Diseases in Familial and Sporadic Type 1 Diabetes is Related to Age at Diabetes Onset 43
Monitoraggio in continuo del glucosio (CGM) in donne con diagnosi di diabete gestazionale suddivise in base al BMI pregravidico 41
Insulin degludec in the first trimester of pregnancy: Report of two cases 41
Screening of postpartum diabetes in women with gestational diabetes: high-risk subgroups and areas for improvements-the STRONG observational study 41
OGTT alla diagnosi di diabete gestazionale e complicanze materne e neonatali 37
Gestational diabetes and maternal-neonatal outcomes: importance of different OGTT alterations 37
Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study 37
Semaglutide: a game changer for metabolic diseases? 36
Gestational Diabetes Mellitus pregnancy by pregnancy: early, late and nonrecurrent GDM 35
Impatto clinico dei nuovi criteri diagnostici del diabete gestazionale in gravidanza e dopo il parto 32
Lateral neck thyroid cancer in a patient with histological benign thyroid 31
Programmazione della gravidanza in donne con diabete mellito tipo 1: motivazioni e timori 31
Excessive generalized and visceral adiposity is associated with a higher prevalence of diabetic retinopathy in Caucasian patients with type 2 diabetes 31
Analoghi dell’insulina e cancro 25
Efficacy of a phone reminder to improve adherence to post-partum glucose tolerance testing after gestational diabetes and clinical predictors of post-partum follow-up compliance 24
Nutritional profile and vision-related quality of life in type 2 diabetes subjects with and without retinopathy: a cross sectional study 23
Efficacia del Flash Glucose Monitoring in donne con diabete pregestazionale 21
Diabete tipo 1 familiare e malattie autoimmuni extra-pancreatiche 19
Semaglutide 17
Alpha-tocopherol and contrast-induced nephropathy: A meta-analysis of randomized controlled trials 17
Short-term adverse affects of anticancer drugs in type 2 diabetes patients. 16
RUOLO DI EPIGENETICA E ALIMENTAZIONE NELLA RETINOPATIA DEL DIABETE MELLITO DI TIPO 2: STUDIO TRASVERSALE 16
Cancer drugs and diabetic retinopathy: a dangerous, underestimated association 15
Valutazione metabolica in soggetti guariti da neoplasia insorta in età pediatrica 14
Gestione del paziente con diabete e cancro: è tempo di un approccio dedicato/integrato 14
Tocoferolo e nefropatia da mezzo di contrasto: meta-analisi di studi randomizzati caso-controllo. 11
MicroRNA miR-146a-5p is reduced in serum of patients with familial vs sporadic type 1 diabetes and targets genes related to type 1 interferon pathway 10
Totale 1.664
Categoria #
all - tutte 7.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 10 0 5 1 7 3
2020/202186 0 4 12 2 17 2 9 3 20 3 10 4
2021/2022173 15 18 3 0 33 1 22 8 17 0 10 46
2022/2023317 32 8 15 31 11 55 1 62 68 5 17 12
2023/2024314 5 31 7 6 6 86 10 48 4 11 52 48
2024/2025664 19 140 61 85 217 128 14 0 0 0 0 0
Totale 1.664